Bruker BRKR
NASDAQ BRKR
$53.55 -0.88 (-1.62%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bruker (BRKR) Total Non-Current Liabilities (2010 - 2026)

Bruker's (BRKR) quarterly Total Non-Current Liabilities came in at $3.1 billion in Q2 2026, down 19.06% on a YoY basis from $3.8 billion in Q2 2025, and little changed quarter-over-quarter from $3.1 billion in Q1 2026.

Analysis

Bruker (BRKR) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Bruker (BRKR) has reported Total Non-Current Liabilities for 17 consecutive years, with $3.1 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Non-Current Liabilities fell 19.06% year-over-year to $3.1 billion; the trailing twelve-month figure through Jun 2026 stood at $3.1 billion (down 19.06% YoY), and the FY2025 full-year result was $3.1 billion, down 14.91% from the prior year.
  • Total Non-Current Liabilities steadied at $3.1 billion in Q2 2026 per BRKR's latest filing, from $3.1 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $4.1 billion in Q3 2024 and bottomed at $2.0 billion in Q2 2022.
  • Historically, Total Non-Current Liabilities has averaged $2.9 billion across 5 years, with a median of $3.0 billion in 2024.
  • The sharpest annual moves came in 2024 and 2026: Total Non-Current Liabilities jumped 85.72% in 2024, then fell 19.06% in 2026.
  • Over 5 years, Total Non-Current Liabilities stood at $2.4 billion in 2022, then grew by 10.05% to $2.6 billion in 2023, then soared by 41.75% to $3.7 billion in 2024, then slipped by 14.91% to $3.1 billion in 2025, then fell by 2.45% to $3.1 billion in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $3.1 billion, $3.1 billion, and $3.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Thermo Fisher Scientific 223.99 Bn 219.93 Bn 8.34 Bn 55.95 Bn
2 Danaher 141.56 Bn 137.22 Bn 3.61 Bn 33.25 Bn
3 Agilent Technologies 40.36 Bn 38.60 Bn 1.04 Bn 6.06 Bn
4 Illumina 30.41 Bn 29.24 Bn 770.00 Mn 3.52 Bn
5 Revvity 13.50 Bn 12.48 Bn 416.87 Mn 4.05 Bn
6 Bio-Techne 11.25 Bn 10.98 Bn 211.39 Mn 457.16 Mn
7 Bio-Rad Laboratories 9.88 Bn 8.26 Bn 345.80 Mn 2.88 Bn
8 Repligen 9.29 Bn 8.28 Bn 110.04 Mn 821.06 Mn
9 10x Genomics 8.62 Bn 8.06 Bn 112.50 Mn 197.96 Mn
10 Bruker 8.16 Bn 7.94 Bn 416.00 Mn 3.06 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.06 Bn
Mar 31, 2026 3.05 Bn
Dec 31, 2025 3.13 Bn
Sep 30, 2025 3.30 Bn
Jun 30, 2025 3.77 Bn
Mar 31, 2025 3.44 Bn
Dec 31, 2024 3.68 Bn
Sep 30, 2024 4.06 Bn
Jun 30, 2024 3.90 Bn
Mar 31, 2024 2.89 Bn
Dec 31, 2023 2.60 Bn
Sep 30, 2023 2.19 Bn
Jun 30, 2023 2.19 Bn
Mar 31, 2023 2.17 Bn
Dec 31, 2022 2.36 Bn
Sep 30, 2022 2.01 Bn
Jun 30, 2022 2.00 Bn
Mar 31, 2022 2.09 Bn
Dec 31, 2021 2.40 Bn
Sep 30, 2021 1.64 Bn